What makes psoriatic and rheumatoid arthritis so different? - Wikidata - wikimedia - TriplyDB

What makes psoriatic and rheumatoid arthritis so different?

What makes psoriatic and rheumatoid arthritis so different?

http://www.wikidata.org/entity/Q26778261

about

Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis.Extracellular vesicles regulate the human osteoclastogenesis: divergent roles in discrete inflammatory arthropathies.Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases.Umbilical cord blood stem cell treatment for a patient with psoriatic arthritis.The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis.Distinguishing rheumatoid arthritis from psoriatic arthritis

P2860

Q33651093-E596B4CA-CC4F-4A9C-BBE4-C07F0E949FFB Q37713522-BF18E719-FAA2-40AC-A5DD-3346D138A7DE Q38792591-44CDA808-6046-4046-9BB1-7B76D1D7763B Q39650675-C3C639F8-BCFC-432C-A7BF-D8FC0491B77B Q47409766-7D08CF90-FB38-4A99-85D9-0D0C0BB4DA82 Q48283709-494CE024-63C8-4A8F-B5F9-F5362A74FBDD Q48339070-D07782E9-6563-4736-93C6-8D4C57E64444 Q54979857-69165491-4EB4-4DF9-8523-C6506F212E52 Q58785143-5BD4D445-7962-40CF-9E6C-8848688E259E

P2860

What makes psoriatic and rheumatoid arthritis so different?

http://www.wikidata.org/entity/Q26778261

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

What makes psoriatic and rheumatoid arthritis so different?

@ast

What makes psoriatic and rheumatoid arthritis so different?

@en

What makes psoriatic and rheumatoid arthritis so different?

@nl

type

label

What makes psoriatic and rheumatoid arthritis so different?

@ast

What makes psoriatic and rheumatoid arthritis so different?

@en

What makes psoriatic and rheumatoid arthritis so different?

@nl

prefLabel

What makes psoriatic and rheumatoid arthritis so different?

@ast

What makes psoriatic and rheumatoid arthritis so different?

@en

What makes psoriatic and rheumatoid arthritis so different?

@nl

P1433

Q26778261-26DC4F42-1AE1-44AA-8199-81163C2C9DCA

P1476

Q26778261-0BF270ED-E4E0-4AB7-A3DE-B961D6E05A8E

P2093

Q26778261-15562A28-50FE-4237-856A-BC8E96F3A22A

P2860

Q26778261-00B66835-9961-4986-BE22-0E0139DE0408

Q26778261-04B28B75-0D8E-4AC9-A550-C1F2686B5A12

Q26778261-0B979F5A-FB65-4BA0-9C8D-6443B32383A4

Q26778261-120DA256-B9D7-4794-B239-A15A0E12D9E1

Q26778261-16CAE507-2FB0-4C36-A837-97C8FB493F7C

Q26778261-28D96260-10A5-484E-A191-33F9EBAAF534

Q26778261-2FABF523-622F-4BDF-92F0-B12C5AF0D66C

Q26778261-384F9F4E-57EB-4D55-BB3C-97BCE9CB8E42

Q26778261-605BE4E3-8348-46FC-B3DD-DA64E792E809

Q26778261-613C67B3-3967-4D9F-885E-1558E4647D5B

P304

Q26778261-90F95260-EB53-4E39-8DFF-BAD67F407D14

P31

Q26778261-7741F6B1-8656-4F7C-A8D0-D67915B9E1B3

P356

Q26778261-D3BC8328-7FFB-45C5-B342-596D7DF4556F

P407

Q26778261-E0997145-1321-49D2-9619-F26C209A2360

P433

Q26778261-F91E926F-9CB5-4C7F-A75D-C29660DE5CE1

P478

Q26778261-7B3AD5D3-E194-4077-AB4E-6C35A6E78264

P50

Q26778261-A57F29B2-9FB0-4B26-9B17-1C27B3B2E186

Q26778261-D91496EC-E4BB-4C7E-A07D-8642D0D5C9FC

P577

Q26778261-6B550688-BFF8-47BD-8DBB-8281DB3FFC77

P5875

Q26778261-244D1EDF-67A4-4F45-8DCF-398F8C2D24B6

P698

Q26778261-2A5CEF4C-C29B-4FCF-9244-9042580C384B

P932

Q26778261-696EDE62-687B-49A0-BE75-7A1ADC2A92A1

P356

RMDOPEN-2014-000025

P1433

P1476

What makes psoriatic and rheumatoid arthritis so different?

@en

P2093

Douglas James Veale

http://www.w3.org/2001/XMLSchema#string

P2860

A proposed classification of the immunological diseases

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Familial occurrence of psoriatic arthritis.

Psoriatic arthritis: a unified concept twenty years on.

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phas

Remission in psoriatic arthritis: is it possible and how can it be predicted?

One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study.

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.

Immunopathology of psoriasis and psoriatic arthritis

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.

P304

e000025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/RMDOPEN-2014-000025

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Douglas J Veale

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276124726

http://www.w3.org/2001/XMLSchema#string

P698

26509055

http://www.w3.org/2001/XMLSchema#string

P932

4613157

http://www.w3.org/2001/XMLSchema#string